BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36313772)

  • 21. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
    Kim KS; Pae CU; Chae JH; Bahk WM; Jun TY; Kim DJ; Dickson RA
    J Clin Psychiatry; 2002 May; 63(5):408-13. PubMed ID: 12019665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.
    Kinon BJ; Ahl J; Liu-Seifert H; Maguire GA
    Psychoneuroendocrinology; 2006 Jun; 31(5):577-88. PubMed ID: 16488084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aripiprazole for drug-induced sexual dysfunction in schizophrenic males].
    Gao LJ; Guo HG; Liang ZT; Zhong XX; Zhu JC; Yang Y
    Zhonghua Nan Ke Xue; 2017 Jul; 23(7):615-619. PubMed ID: 29723454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics.
    Liu-Seifert H; Ascher-Svanum H; Osuntokun O; Jen KY; Gomez JC
    BMC Psychiatry; 2011 May; 11():87. PubMed ID: 21586165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
    Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ; Gilmore JA; Liu H; Halbreich UM
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.
    Tsuboi T; Bies RR; Suzuki T; Mamo DC; Pollock BG; Graff-Guerrero A; Mimura M; Uchida H
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():178-82. PubMed ID: 23727135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.
    Volavka J; Czobor P; Cooper TB; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA
    J Clin Psychiatry; 2004 Jan; 65(1):57-61. PubMed ID: 14744169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.
    Jeong HG; Lee MS; Lee HY; Ko YH; Han C; Joe SH
    Int Clin Psychopharmacol; 2012 Jul; 27(4):177-83. PubMed ID: 22407277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between serum testosterone levels, body mass index (BMI) and insulin in male patients with schizophrenia treated with atypical antipsychotics--olanzapine or risperidone.
    Konarzewska B; Galińska-Skok B; Waszkiewicz N; Łazarczyk-Kirejczyk J; Malus A; Simonienko K; Szulc A
    Neuro Endocrinol Lett; 2014; 35(1):50-7. PubMed ID: 24625910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.
    Iwata Y; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Plitman E; Chung JK; Mar W; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Mamo DC; Graff-Guerrero A
    J Clin Psychiatry; 2016 Dec; 77(12):e1557-e1563. PubMed ID: 28086010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study.
    Liu X; Sun X; Li L; Zeng K; Li Y; Gao Y; Ma J
    Front Psychiatry; 2023; 14():1124691. PubMed ID: 36816406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia.
    Suzuki Y; Sugai T; Ono S; Sawamura K; Fukui N; Watanabe J; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2014 May; 68(5):353-6. PubMed ID: 24405493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.